,Name,Title,Company,Person_Location,Company_HQ,Funding_Stage,Published_Last_2_Years,Keywords
0,John Smith,Director of Toxicology,BioX Therapeutics,Boston,Cambridge MA,Series B,Yes,Drug-Induced Liver Injury; Hepatic
1,Anita Rao,Senior Scientist,MedCore Labs,Bangalore,Bangalore,Not Funded,No,Cell Culture
2,Michael Chen,Head of Preclinical Safety,NeoGen Bio,San Diego,Bay Area,Series A,Yes,3D Cell Culture; Toxicology
3,Sarah Williams,Junior Scientist,EarlyBio,Remote Texas,Boston,Seed,No,In-vitro models
4,David Müller,VP Safety Assessment,EuroTox GmbH,Basel,Basel,Series B,Yes,Liver Toxicity; Organ-on-chip
